Literature DB >> 7665646

Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada.

J M Blondeau1, F E Ashton, M Isaacson, Y Yaschuck, C Anderson, G Ducasse.   

Abstract

Moderately penicillin-resistant Neisseria meningitidis is rare in North America. We report an outbreak of meningococcal disease in Saskatoon, Saskatchewan, Canada, with serogroup C N. meningitidis. The MICs of penicillin ranged from 0.12 to 0.25 micrograms/ml, and all isolates showing decreased susceptibility had identical genomic fingerprints when they were compared by pulsed-field gel electrophoresis. Our data indicate that N. meningitidis that is moderately resistant to penicillin is prevalent in Saskatchewan, Canada.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7665646      PMCID： PMC228269          DOI： 10.1128/jcm.33.7.1784-1786.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Penicillin resistance in Neisseria meningitidis.

Authors:  G Riley; S Brown; C Krishnan
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

2.  Neisseria meningitidis with reduced sensitivity to penicillin: observations in 10 children.

Authors:  S Uriz; V Pineda; M Grau; J M Nava; F Bella; M A Morera; D Fontanals; B Font; C Martí; F Deulofeu
Journal:  Scand J Infect Dis       Date:  1991

Review 3.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

4.  Meningococci with reduced susceptibility to penicillin.

Authors:  D M Jones; E M Sutcliffe
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

5.  Meningococcal disease in Ontario during the winter of 1988-1989.

Authors:  G A Heimann; D E Mikel; M Naus; V Goel; M Tischler; J A Carlson; R Schabas; G Pasut; A Borczyk; C Krishnan
Journal:  Can Dis Wkly Rep       Date:  1989-03-18

6.  Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3.

Authors:  P M Mendelman; J Campos; D O Chaffin; D A Serfass; A L Smith; J A Sáez-Nieto
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

7.  Penicillin-insensitive meningococci in the UK.

Authors:  E M Sutcliffe; D M Jones; S el-Sheikh; A Percival
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

8.  Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations.

Authors:  J A Sáez-Nieto; D Fontanals; J Garcia de Jalon; V Martinez de Artola; P Peña; M A Morera; R Verdaguer; I Sanfeliu; C Belio-Blasco; J L Perez-Saenz
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

9.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

10.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490
View more
  6 in total

1.  Complete sequence of a beta-lactamase-encoding plasmid in Neisseria meningitidis.

Authors:  A Bäckman; P Orvelid; J A Vazquez; O Sköld; P Olcén
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Therapy of suspected bacterial meningitis in Canadian children six weeks of age and older.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-03       Impact factor: 2.253

3.  Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.

Authors:  T Popovic; S Schmink; N A Rosenstein; G W Ajello; M W Reeves; B Plikaytis; S B Hunter; E M Ribot; D Boxrud; M L Tondella; C Kim; C Noble; E Mothershed; J Besser; B A Perkins
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.

Authors:  J M Blondeau; Y Yaschuk
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

5.  Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.

Authors:  Mignon du Plessis; Anne von Gottberg; Cheryl Cohen; Linda de Gouveia; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

6.  Molecular characteristics of Neisseria meningitidis in Qatar.

Authors:  Manal Mahmoud Hamed; Fayaz Ahmad Mir; Emad Bashier Ibrahim Elmagboul; Abdullatif Al-Khal; Muna A Rahman S Al Maslamani; Anand Sarwottam Deshmukh; Hamad Eid Al-Romaihi; Mohd Ahmed M Sharif Janahi; Fatma Ben Abid; Adila Shaukat Ali Kashaf; Gulab Sher; Vinod Kumar Gupta; Godwin J Wilson; Junais Kadalayi; Sanjay H Doiphode
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.